|Bid||276.98 x 1000|
|Ask||277.21 x 800|
|Day's range||272.73 - 282.80|
|52-week range||205.10 - 305.21|
|Beta (5Y monthly)||0.74|
|PE ratio (TTM)||68.88|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||23 Nov 2012|
|1y target est||N/A|
NEUCHATEL, Switzerland, November 29, 2021--A large field trial in India used Masimo Rad-G® to aid health providers in pneumonia case detection and management, with 91% correct case management.
IRVINE, Calif., November 23, 2021--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Piper Sandler 33rd Annual Healthcare Conference on Tuesday, November 30, 2021 at 2:00 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.
NEUCHATEL, Switzerland, November 15, 2021--A study found that general anesthesia guided by a combination of Masimo SedLine® processed EEG parameters PSi and DSA reduced postoperative delirium.